- Sarkomycin
- Sarkomycin compounded with nicotinic hydrazide
- 110-31-6N,N'-1,2-Ethanediylbis-9-octadecenamide
- 11032-08-9Thermothiocin
- 11032-49-8Vitamin K 2
- 11032-50-1Vitamin PP
- 11032-79-4alpha-Bungarotoxin
- 110332-91-7PPG-2 isoceteth-20 acetate
- 110333-07-8Quinoline, 5-(chloromethyl)-
- 110-33-8Hexanedioic acid,1,6-dihexyl ester
- 1103-38-41-Naphthalenesulfonicacid, 2-[2-(2-hydroxy-1-naphthalenyl)diazenyl]-, barium salt (2:1)
- 1103-39-51-Naphthalenesulfonicacid, 2-[2-(2-hydroxy-1-naphthalenyl)diazenyl]-, calcium salt (2:1)
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
Sarkomycin |
EINECS | N/A |
| CAS No. | 11031-48-4 | Density | 1.23g/cm3 |
| PSA | N/A | LogP | N/A |
| Solubility | N/A | Melting Point |
N/A |
| Formula | C7H8O3 | Boiling Point | 320.3°Cat760mmHg |
| Molecular Weight | 140.15 | Flash Point | 161.8°C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Moderately toxic by intravenous, subcutaneous, and intraperitoneal routes. Mildly toxic by ingestion. Experimental teratogenic and reproductive effects. Questionable carcinogen with experimental tumorigenic data. Mutation data reported. Used as an antibiotic. When heated to decomposition it emits acrid smoke and irritating fumes. | Risk Codes | N/A |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
Sarcomycin(8CI) |
Article Data | 19 |
Sarkomycin Chemical Properties
Molecule structure of Sarkomycin (CAS NO.11031-48-4) :
IUPAC Name: (1S)-2-methylidene-3-oxocyclopentane-1-carboxylic acid
Molecular Weight: 140.13662 g/mol
Molecular Formula: C7H8O3
Density: 1.23 g/cm3
Boiling Point: 320.3 °C at 760 mmHg
Flash Point: 161.8 °C
Index of Refraction: 1.506
Molar Refractivity: 33.69 cm3
Molar Volume: 113.3 cm3
Polarizability: 13.35×10-24 cm3
Surface Tension: 43.6 dyne/cm
Enthalpy of Vaporization: 61.79 kJ/mol
Vapour Pressure: 6.65E-05 mmHg at 25 °C
XLogP3-AA: 0.2
H-Bond Donor: 1
H-Bond Acceptor: 3
Rotatable Bond Count: 1
Tautomer Count: 2
Exact Mass: 140.047344
MonoIsotopic Mass: 140.047344
Topological Polar Surface Area: 54.4
Heavy Atom Count: 10
Complexity: 205
Defined Atom StereoCenter Count: 1
Canonical SMILES: C=C1C(CCC1=O)C(=O)O
Isomeric SMILES: C=C1[C@H](CCC1=O)C(=O)O
InChI: InChI=1S/C7H8O3/c1-4-5(7(9)10)2-3-6(4)8/h5H,1-3H2,(H,9,10)/t5-/m0/s1
InChIKey of Sarkomycin (CAS NO.11031-48-4) : ILFPCMXTASDZKM-YFKPBYRVSA-N
Sarkomycin Toxicity Data With Reference
| 1. | mmo-eug 10 µg/L | NEOLA4 Neoplasma. 19 (1972),579. | ||
| 2. | dni-eug 10 µg/L | NEOLA4 Neoplasma. 19 (1972),579. | ||
| 3. | orl-mus LD50:5600 mg/kg | 85ERAY Antibiotics: Origin, Nature, and Properties. 2 (1978),1261. | ||
| 4. | ipr-mus LDLo:700 mg/kg | TDKNAF Takeda Kenkyusho Nempo. Annual Report of the Takeda Research Laboratories. 14 (1955),60. | ||
| 5. | scu-mus LD50:600 mg/kg | 85ERAY Antibiotics: Origin, Nature, and Properties. 2 (1978),1261. | ||
| 6. | ivn-mus LD50:1200 mg/kg | 85ERAY Antibiotics: Origin, Nature, and Properties. 2 (1978),1261. |
Sarkomycin Safety Profile
Moderately toxic by intravenous, subcutaneous, and intraperitoneal routes. Mildly toxic by ingestion. Experimental teratogenic and reproductive effects. Questionable carcinogen with experimental tumorigenic data. Mutation data reported. Used as an antibiotic. When heated to decomposition it emits acrid smoke and irritating fumes.
What can I do for you?
Get Best Price
